Progress in research of influenza vaccination in pregnant women.
10.3760/cma.j.cn112338-20221012-00877
- Author:
Si Meng FAN
1
;
Xiao Kun YANG
1
;
Hong Ting ZHAO
1
;
Ying QIN
1
;
Jian Dong ZHENG
1
;
Zhi Bin PENG
1
;
Yan Ping ZHANG
1
;
Zi Jian FENG
2
Author Information
1. Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
2. Chinese Center for Disease Control and Prevention, Beijing 102206, China.
- Publication Type:Journal Article
- MeSH:
Pregnancy;
Female;
Humans;
Pregnant Women;
Influenza, Human/epidemiology*;
Pregnancy Complications, Infectious/epidemiology*;
Influenza Vaccines;
Vaccination;
Orthomyxoviridae
- From:
Chinese Journal of Epidemiology
2023;44(7):1157-1162
- CountryChina
- Language:Chinese
-
Abstract:
Influenza is an acute respiratory infectious disease caused by influenza virus. Pregnancy is associated with physiologic and immunological changes that may increase the risk for influenza virus infection and influenza-related complications. Influenza vaccination is the most effective way to prevent influenza virus infection. WHO and many countries have classified pregnant women as a priority population for influenza vaccination, however, there are still many challenges for promoting influenza vaccination in pregnant women in China, influenza vaccination coverage in pregnant women remains low and some influenza vaccine package inserts list pregnancy as an absolute contraindication. In this paper, we summarize the research progress in the effects of influenza infection and influenza vaccination during pregnancy both at home and abroad, then discuss the strategies to promote influenza vaccination in pregnancy for the purpose of providing reference for the related research and policy development in China.